Vertex
Vertex ditches its once-stellar hep C drug
August 14, 2014Sales and Marketing Gilead, Incivek, Vertex, hep C, sovaldi
Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …
Janssen and GSK in hep C tie-ups
November 8, 2012Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C
Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …
Vertex abandons hep C drug
September 27, 2012Research and Development, Sales and Marketing Alios BioPharma, Vertex, hep C
Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …
Vertex admits blunder over drug data
May 31, 2012Sales and Marketing Kalydeco, Kalydeco., Vertex, cystic fibrosis
Vertex has been embarrassed after it released claims for its pipeline drug VX-809 which turned out to be incorrect. The …
Landmark CF treatment set for European approval
May 30, 2012Sales and Marketing CHMP, Europe, Kalydeco, Vertex, cystic fibrosis
A European committee is recommending the approval of Vertex’s first-in-class treatment for cystic fibrosis. Kalydeco (ivacaftor) is a landmark in …
Groundbreaking CF drug recommended in Europe
May 25, 2012Sales and Marketing CHMP, EMA, Kalydeco, Vertex, cystic fibrosis
The first-in-class treatment for cystic fibrosis Kalydeco has been recommended by the EMA’s medicines committee. Kalydeco (ivacaftor) promises to be …
Kalydeco to be landmark in cystic fibrosis treatment
February 1, 2012Vertex, cystic fibrosis, telaprevir
Vertex’s first-in-class treatment for cystic fibrosis Kalydeco has been approved by the FDA. The approval is a landmark in the …
Vertex chief to step down; names Jeffrey Leiden as new leader
December 19, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex
Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …
J&J and Vertex’s hep C drug Incivek approved by FDA
May 24, 2011Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir
The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …
Vertex’s cystic fibrosis drug shows huge promise
February 28, 2011Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis
US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …
